{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T11:12:20Z","timestamp":1723029140616},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.2169\/internalmedicine.6026-20","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T22:10:48Z","timestamp":1619820648000},"page":"1433-1442","source":"Crossref","is-referenced-by-count":1,"title":["The Amount of Residual Incretin Regulates the Pancreatic \u03b2-cell Function and Glucose Homeostasis"],"prefix":"10.2169","volume":"60","author":[{"given":"Tatsuya","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Kitano","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobukazu","family":"Miyakawa","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rieko","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Hanatani","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaji","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Igata","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Motoshima","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Seino Y, Fukushima M, Yabe D. GIP and GLP-1, the two incretin hormones: Similarities and differences. J Diabetes Investig 1: 8-23, 2010."},{"key":"2","unstructured":"2. Seino Y, Yabe D. Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: incretin actions beyond the pancreas. J Diabetes Investig 4: 108-130, 2013."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tura A, Pacini G, Yamada Y, Seino Y, Ahren B. Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice. Am J Physiol Regul Integr Comp Physiol 316: R27-R37, 2019.","DOI":"10.1152\/ajpregu.00288.2018"},{"key":"4","unstructured":"4. Hansotia T, Drucker DJ. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice. Regul Pept 128: 125-134, 2005."},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Holst JJ. The incretin system in healthy humans: the role of GIP and GLP-1. Metabolism 96: 46-55, 2019.","DOI":"10.1016\/j.metabol.2019.04.014"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Yamazaki H, Matsuoka K, Fernandez J, et al. Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network). BMJ Open 9: e030134, 2019.","DOI":"10.1136\/bmjopen-2019-030134"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jensen AB, Sorensen TI, Pedersen O, Jess T, Brunak S, Allin KH. Increase in clinically recorded type 2 diabetes after colectomy. Elife 7: e37420, 2018.","DOI":"10.7554\/eLife.37420"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Grasset E, Puel A, Charpentier J, et al. A specific gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance through an enteric NO-dependent and Gut-Brain axis mechanism. Cell Metab 25: 1075-1090 e1075, 2017.","DOI":"10.1016\/j.cmet.2017.04.013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yadav H, Lee JH, Lloyd J, Walter P, Rane SG. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem 288: 25088-25097, 2013.","DOI":"10.1074\/jbc.M113.452516"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Jorsal T, Rhee NA, Pedersen J, et al. Enteroendocrine K and L cells in healthy and type 2 diabetic individuals. Diabetologia 61: 284-294, 2018.","DOI":"10.1007\/s00125-017-4450-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Palnaes Hansen C, Andreasen JJ, Holst JJ. The release of gastric inhibitory peptide, glucagon-like peptide-I, and insulin after oral glucose test in colectomized subjects. Scand J Gastroenterol 32: 473-477, 1997.","DOI":"10.3109\/00365529709025084"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Duan L, Rao X, Braunstein Z, Toomey AC, Zhong J. Role of incretin axis in inflammatory bowel disease. Front Immunol 8: 1734, 2017.","DOI":"10.3389\/fimmu.2017.01734"},{"key":"13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2337\/dc16-1324","volume":"40","author":"J de la Cuesta-Zuluaga","year":"2017","unstructured":"13. de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V, et al. Metformin is associated with higher relative abundance of mucin-degrading akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care 40: 54-62, 2017.","journal-title":"Diabetes Care","ISSN":"http:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"14","unstructured":"14. Usui R, Sakuramachi Y, Seino Y, et al. Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: the association between remaining beta-cell function and the achievement of the HbA1c target 1 year after initiation. J Diabetes Investig 9: 981-983, 2018."},{"key":"15","unstructured":"15. Usui R, Yabe D, Kuwata H, Murotani K, Kurose T, Seino Y. Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: association of remaining beta-cell function and achievement of HbA1c target one year after initiation. J Diabetes Complications 29: 1203-1210, 2015."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Piccand J, Vagne C, Blot F, et al. Rfx6 promotes the differentiation of peptide-secreting enteroendocrine cells while repressing genetic programs controlling serotonin production. Mol Metab 29: 24-39, 2019.","DOI":"10.1016\/j.molmet.2019.08.007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14: 20-32, 2016.","DOI":"10.1038\/nrmicro3552"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/9\/60_6026-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T03:54:12Z","timestamp":1619841252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/9\/60_6026-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6026-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}